[{"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q2_USD":79993000.0,"MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments_2_Q2_USD":219000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":4996000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-152339000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":82474000.0,"NetIncomeLoss_2_Q2_USD":29420000.0,"NetIncomeLoss_1_Q2_USD":23726000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":23726000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":29420000.0,"NonoperatingIncomeExpense_1_Q2_USD":-2878000.0,"NonoperatingIncomeExpense_2_Q2_USD":-5163000.0,"NumberOfOperatingSegments_2_Q2_segment":1.0,"OperatingIncomeLoss_1_Q2_USD":34113000.0,"OperatingIncomeLoss_2_Q2_USD":47327000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":5900000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":36143000.0,"MarketableSecuritiesNoncurrent_0_Q2_USD":445473000.0,"OperatingLeasePayments_2_Q2_USD":4036000.0,"MarketableSecuritiesCurrent_0_Q2_USD":186070000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":1573060000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2_Q2_shares":1616061.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":352628000.0,"InterestExpense_2_Q2_USD":11564000.0,"InterestExpense_1_Q2_USD":5467000.0,"InterestExpenseDebt_1_Q2_USD":4498000.0,"InterestExpenseDebt_2_Q2_USD":9560000.0,"InterestExpenseOther_1_Q2_USD":969000.0,"InterestExpenseOther_2_Q2_USD":2004000.0,"InterestPaidNet_2_Q2_USD":1258000.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":15039000.0,"InventoryNet_0_Q2_USD":58391000.0,"InventoryWorkInProcessAndRawMaterialsNetOfReserves_0_Q2_USD":28159000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":15193000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_2_Q2_USD":2371000.0,"Liabilities_0_Q2_USD":787481000.0,"LiabilitiesCurrent_0_Q2_USD":283447000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q2_shares":1718802.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":29665000.0,"OtherAssetsNoncurrent_0_Q2_USD":40687000.0,"PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_0_Q2_USD":27624000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":15455000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":49735000.0,"ResearchAndDevelopmentInProcess_2_Q2_USD":15000000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":355918000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":141329000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":272261000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":69535000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":130992000.0,"ShareBasedCompensation_2_Q2_USD":9847000.0,"StockholdersEquity_0_Q2_USD":785579000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":2749000.0,"UnrealizedGainLossOnDerivatives_2_Q2_USD":7730000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":54601533.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":54724146.0,"PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_0_Q2_USD":17065000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":8550000.0,"PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_0_Q2_USD":10559000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":4996000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":-816000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":-3542000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":-816000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":-3542000.0,"OtherLiabilitiesCurrent_0_Q2_USD":6316000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":19092000.0,"OtherNoncashIncomeExpense_2_Q2_USD":651000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":2589000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":6401000.0,"OtherSundryLiabilitiesNoncurrent_0_Q2_USD":9068000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_2_Q2_USD":950000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":233272000.0,"PaymentsToAcquireOtherInvestments_2_Q2_USD":0.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":1508000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":33737000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":83844000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":18003000.0,"IncreaseDecreaseInInventories_2_Q2_USD":7950000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-3605000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":293000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":624324000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q2_USD":186070000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":631543000.0,"BusinessCombinationConsiderationTransferred1_2_Q2_USD":0.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q2_USD":-8750000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2_Q2_USD":-7730000.0,"BusinessCombinationContingentConsiderationLiability_0_Q2_USD":68970000.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q2_USD":23540000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q2_USD":45430000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":223771000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":223771000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-64869000.0,"ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0_Q2_USD":80.9063,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":7512000.0,"CommonStockSharesAuthorized_0_Q2_shares":130000000.0,"AssetsCurrent_0_Q2_USD":639244000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":11955000.0,"AccountsPayableCurrent_0_Q2_USD":7229000.0,"AccountsReceivableNetCurrent_0_Q2_USD":137275000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":79993000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":11993000.0,"AccruedRoyaltiesCurrent_0_Q2_USD":13183000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":5433000.0,"AdditionalPaidInCapital_0_Q2_USD":424175000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":5476000.0,"AdvertisingExpense_1_Q2_USD":21800000.0,"AdvertisingExpense_2_Q2_USD":37100000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":5476000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":9847000.0,"AmortizationOfFinancingCostsAndDiscounts_1_Q2_USD":4300000.0,"AmortizationOfFinancingCostsAndDiscounts_2_Q2_USD":8632000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":5948000.0,"Assets_0_Q2_USD":1573060000.0,"CommonStockSharesIssued_0_Q2_shares":53144759.0,"CommonStockSharesOutstanding_0_Q2_shares":52868482.0,"CommonStockValue_0_Q2_USD":53000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_2_Q2_USD":-7730000.0,"FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0_Q2_USD":68970000.0,"FinanceLeaseLiabilityCurrent_0_Q2_USD":0.0,"FinanceLeaseLiabilityNoncurrent_0_Q2_USD":0.0,"FinanceLeaseRightOfUseAsset_0_Q2_USD":0.0,"FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_0_Q2_USD":0.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":46192000.0,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":398820000.0,"Goodwill_0_Q2_USD":77963000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":31235000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":42164000.0,"IncomeTaxesPaidNet_2_Q2_USD":20696000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":7509000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":12744000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":-5679000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":12926000.0,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.302,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":0.241,"EarningsPerShareDiluted_1_Q2_USD":0.43,"ComprehensiveIncomeNetOfTax_1_Q2_USD":22910000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":25878000.0,"ConvertibleLongTermNotesPayable_0_Q2_USD":370383000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":25028000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":39982000.0,"CostsAndExpenses_1_Q2_USD":107216000.0,"CostsAndExpenses_2_Q2_USD":224934000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":53005344.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded_2_Q2_USD":0.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":32986000.0,"DepreciationAndAmortization_1_Q2_USD":700000.0,"DepreciationAndAmortization_2_Q2_USD":1300000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":13213000.0,"EarningsPerShareBasic_1_Q2_USD":0.45,"EarningsPerShareBasic_2_Q2_USD":0.56,"EarningsPerShareDiluted_2_Q2_USD":0.54,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":-2046000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":52985472.0,"Ticker":"SUPN","CIK":"1356576","name":"SUPERNUS PHARMACEUTICALS, INC.","OfficialName":"Supernus Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1557812380.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210806"}]